Supplements and heart health
Niacin (Vitamin B3) for Cholesterol: the Evidence, and the Bloods to Do First
Reviewed by a qualified clinician · analysed at UKAS-accredited UK labs (ISO 15189)
Last reviewed August 20267 min read
Every Helvy guide is written by our health editors, then checked by a qualified clinician before it goes live and re-checked as the science moves. We name clinical roles, not individuals, until each reviewer has agreed to be credited publicly. This is wellness guidance to help you understand your own data, not a diagnosis.
QUICK ANSWER
At gram doses, niacin genuinely moves lipids. A meta-analysis of 14 trials found it cut Lp(a) by about 23%. But two large trials adding niacin to a statin found no drop in heart attacks or strokes, and high doses can damage the liver. NICE does not recommend it. If you try it, measure Lp(a) and ALT first.
Niacin is the supplement people reach for after a bad cholesterol result. It is cheap, it is sold in every health shop, and it has a real pharmacological effect. That last part is unusual on a supplement shelf, and it is why the topic keeps coming back.
It is also why the story is more awkward than either side admits. Niacin changes your numbers. Two large trials then failed to show that changing those particular numbers helped. Both statements are true, and the gap between them is the whole guide.
By the Helvy Medical Team · Reviewed by a qualified clinician · 7 min read
As of August 2026. Reflects HPS2-THRIVE (New England Journal of Medicine, July 2014), the 2016 Metabolism meta-analysis on Lp(a), and the February 2024 Nature Medicine paper on the niacin breakdown product 4PY.
1. What niacin is, and why it is back
Niacin is vitamin B3. Your body needs a small amount of it every day. The NHS puts that at about 16.5mg a day for men and 13.2mg a day for women, which most UK diets supply without effort.
The lipid doses are a different animal. Trials use 1 to 3 grams a day, which is roughly a hundred times the daily requirement. At that dose it is not really a vitamin any more. It is a drug you can buy without a prescription.
Two things have pulled it back into view. The NAD+ longevity wave has put every form of B3 back on the shelf, which our guide to NMN and NAD+ supplements covers. And supplement forums keep resurfacing niacin as the old-school answer to a high cholesterol result.
2. Does niacin lower cholesterol and Lp(a)?
Yes. This is the part nobody disputes. At gram doses niacin lowers LDL and triglycerides, raises HDL, and does something almost nothing else in a health shop can do. It lowers Lp(a).
The best number we have comes from a 2016 systematic review and meta-analysis in Metabolism. It pooled 14 randomised placebo-controlled trials covering 9,013 people. Extended-release niacin cut Lp(a) by 22.9% against placebo.
That matters because Lp(a) is stubborn. It is set almost entirely by your genes. Diet barely touches it, exercise barely touches it, and statins do not lower it. So a cheap tablet that moves it by a fifth is interesting on paper.
Response varies a lot between people, though. The same literature records some people dropping far more than 23% and others barely moving. That is the first argument for measuring rather than assuming.
3. The markers to measure, before and after
If you are going to take a gram of anything daily, measure. Two questions need answering: is it working, and is it costing you anything. Four markers cover both.
- Lp(a) — the one lipid niacin uniquely moves, and it is not in a standard NHS lipid panel
- ApoB — counts the harmful particles, rather than the fat inside them
- ALT — the liver enzyme that tells you whether the dose is doing harm
- HbA1c— niacin nudges blood sugar upward, so this is the side effect worth watching
Our Advanced Heart Health panel (£159) measures Lp(a), ApoB, hs-CRP, HbA1c and the full lipid breakdown from a home finger-prick sample. ALT sits in our Thyroid & Vital Organs panel (£159) alongside the kidney and thyroid markers. All samples are analysed by UKAS-accredited UK laboratories.
Blood markers describe risk. They cannot see plaque inside an artery, so a good result is a reassuring picture rather than an all-clear. What they can do is turn a supplement decision into an experiment with a before and an after. More on the wider set in our cholesterol blood test guide.
4. So why did the big trials fail?
Here is the turn in the story. Niacin moved the numbers. It did not move the outcomes.
AIM-HIGH gave extended-release niacin to 3,414 people with heart disease who were already on simvastatin. HDL rose. Triglycerides fell. The trial was stopped 18 months early in 2011 because the heart attack and stroke rate was no different from placebo.
Then came the big one. HPS2-THRIVE, run by Oxford’s Clinical Trial Service Unit and published in the New England Journal of Medicine in July 2014, randomised 25,673 high-risk patients across six countries. The trialists summarise the finding plainly:
“[Niacin] did not significantly reduce the risk of major vascular events… compared to placebo.”
— HPS2-THRIVE, University of Oxford Clinical Trial Service Unit
Worse, harm went up. The same trial reported more new diabetes, more bleeding, more infection, and a roughly fourfold rise in statin-related muscle injury.
This is why NICE guideline NG238 tells clinicians not to offer nicotinic acid to prevent cardiovascular disease. Note the scope of that verdict, though. Both trials tested niacin on top of a statin, in people whose LDL was already treated. Neither was designed around Lp(a).
A newer finding complicates it further. A February 2024 Nature Medicine study from the Cleveland Clinic found that 4PY, a breakdown product of niacin, was linked to more heart attacks and strokes, and drove inflammation in blood vessels in laboratory work. It is an association plus a mechanism, not proof. But it offers one possible reason the trials came out flat.
5. The liver problem, and the flush-free trap
The NHS is direct about the risk of taking too much:
“Taking high doses of nicotinic acid supplements can cause skin flushes. Taking high doses for a long time could lead to liver damage.”
— NHS, B vitamins and folic acid
The LiverTox database puts numbers on it. Doses above 500mg a day cause mild, usually harmless rises in liver enzymes in up to a fifth of people. The serious injuries cluster around doses above 3 grams a day.
The formulation matters more than the dose. In one comparison, none of 65 people on regular niacin developed liver injury, while 8 of 15 on sustained-release niacin did. Slow-release forms carry the risk, and they are exactly what a shopper reaches for to dodge the flush.
Which brings us to the flush-free trap. “No-flush” niacin is usually inositol hexanicotinate, a different molecule. A trial in the Journal of Clinical Lipidology found it no better than placebo on lipids, with no sign it was even absorbed as niacin. It is the most comfortable version and the least useful one.
So the honest summary is uncomfortable. The version that works is the one that makes you flush. The version that hides the flush either does nothing or carries the liver risk. Either way, an ALT reading before you start gives you a baseline to compare against.
6. If your real worry is chest tightness
Some of the current interest in B3 comes from forum posts about chest tightness easing. Read that carefully, because it is the one thread here that should not end at a supplement.
Chest tightness, chest pain or breathlessness needs a doctor, not a tablet. See your GP. If it comes on suddenly, is severe, or comes with sweating, nausea or pain spreading to your arm or jaw, call 999. No blood test and no supplement substitutes for that call.
Frequently asked questions
Does niacin lower cholesterol?
At gram doses, yes. Niacin lowers LDL and triglycerides and raises HDL. A 2016 meta-analysis of 14 randomised trials in 9,013 people also found extended-release niacin cut Lp(a) by 22.9%. What it did not do, in two large trials, was reduce heart attacks or strokes in people already taking a statin.
Why does NICE not recommend niacin?
Because the outcome trials came out flat. HPS2-THRIVE randomised 25,673 people and found no significant reduction in major vascular events, alongside more new diabetes, bleeding and infection. NICE guideline NG238 tells clinicians not to offer nicotinic acid to prevent cardiovascular disease.
Is niacin bad for your liver?
It can be at high doses. The NHS warns that taking high doses for a long time could lead to liver damage. LiverTox reports mild enzyme rises above 500mg a day and serious injury clustering above 3 grams a day, with sustained-release forms far riskier than plain niacin. An ALT test gives you a baseline.
Is flush-free niacin better?
No. “No-flush” niacin is usually inositol hexanicotinate. A trial in the Journal of Clinical Lipidology found it no better than placebo on lipids, with no evidence it was absorbed as niacin. You lose the flush and the lipid effect together.
Which blood tests should I do before trying niacin?
Lp(a), ApoB and a full lipid breakdown to see whether there is anything to move, plus ALT for liver safety and HbA1c because niacin nudges blood sugar up. Repeat them after about 12 weeks. Talk to your GP first if you take a statin or any prescribed medicine.
Measure it, then decide
Our Advanced Heart Health panel (£159) measures Lp(a), ApoB and hs-CRP alongside HbA1c and the full lipid breakdown. Home finger-prick kit, results usually within 5 working days of the lab receiving your sample, from UKAS-accredited UK laboratories.
Medical disclaimer:This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The studies cited measure population-level effects and may not predict an individual response. Do not start, stop or change any supplement or medication based solely on this article — consult your GP or a qualified healthcare professional. All Helvy blood tests are processed by UKAS-accredited UK laboratories to ISO 15189.
Last updated: August 2026 · By Helvy · Medically analysed at UKAS-accredited UK laboratories
RELATED READING